Client News

Mainz Biomed Partners with Liquid Biosciences to Leverage the Power of Artificial Intelligence for the Expansion and Optimization of Biomarker Selection for PancAlert

InflaRx Presents New Preclinical Findings for INF904 at the 19th European Meeting on Complement in Human Diseases

Rentschler Biopharma Introduces New Lentiviral Vector Manufacturing Toolbox for Advanced Therapies

Nyxoah Rings the Closing Bell at Nasdaq while Preparing for U.S. Market Launch of Innovative Sleep Apnea Device

Syntekabio Introduces Develop Now, Pay Later with AI-powered STB LaunchPad Program

Advanced Medical Balloons Appoints Top-Performing US Life-Science Executive to Drive Business Growth

Medigene AG Secures Two Additional Patents for Technologies in Its End-to-End Platform

InflaRx Announces Participation in September Investor Events

Pentixapharm AG Receives Orphan Drug Designation for its Radiodiagnostic Tracer PentixaFor in Marginal Zone Lymphoma by the European Medicines Agency

Medigene AG Implements Announced 2:1 Share Capital Reduction and Consolidation of the Shares Effective August 29, 2024